BIOMED REALTY TRUST INC 
By SAN DIEGO, Jan. 15 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the tax treatment of its 2009 distributions as follows:
Security Description: Common Stock
CUSIP: 09063H107
Ticker Symbol: BMR
Taxable
Record Payable Total Allocable Ordinary
Date Date Distribution to 2009 Dividend
------ ------- ------------ --------- --------
Return of
Per Share Capital
--------- ---------
12/31/2008 1/15/2009 $0.335000 $0.335000 $0.169216 $0.165784
---------- --------- --------- --------- --------- ---------
3/31/2009 4/15/2009 $0.335000 $0.335000 $0.169216 $0.165784
--------- --------- --------- --------- --------- ---------
6/30/2009 7/15/2009 $0.110000 $0.110000 $0.055564 $0.054436
--------- --------- --------- --------- --------- ---------
9/30/2009 10/15/2009 $0.110000 $0.110000 $0.055564 $0.054436
--------- ---------- --------- --------- --------- ---------
Totals $0.890000 $0.890000 $0.449560 $0.440440
------ --------- --------- --------- ---------
Long-Term Unrecaptured
Record Payable Capital Section 1250
Date Date Gain Gain
------ ------- --------- ------------
12/31/2008 1/15/2009 $0.000000 $0.000000
---------- --------- --------- ---------
3/31/2009 4/15/2009 $0.000000 $0.000000
--------- --------- --------- ---------
6/30/2009 7/15/2009 $0.000000 $0.000000
--------- --------- --------- ---------
9/30/2009 10/15/2009 $0.000000 $0.000000
--------- ---------- --------- ---------
Totals $0.000000 $0.000000
------ --------- ---------
Security Description: 7.375% Series A Cumulative Redeemable Preferred
Stock
CUSIP: 09063H206
Ticker Symbol: BMR PR A
Taxable
Record Payable Total Allocable Ordinary
Date Date Distribution to 2009 Dividend
------ ------- ------------ --------- --------
Return of
Per Share Capital
--------- ---------
12/31/2008 1/15/2009 $0.460940 $0.460940 $0.460940 $0.000000
---------- --------- --------- --------- --------- ---------
3/31/2009 4/15/2009 $0.460940 $0.460940 $0.460940 $0.000000
--------- --------- --------- --------- --------- ---------
6/30/2009 7/15/2009 $0.460940 $0.460940 $0.460940 $0.000000
--------- --------- --------- --------- --------- ---------
9/30/2009 10/15/2009 $0.460940 $0.460940 $0.460940 $0.000000
--------- ---------- --------- --------- --------- ---------
Totals $1.843760 $1.843760 $1.843760 $0.000000
------ --------- --------- --------- ---------
Long-Term Unrecaptured
Record Payable Capital Section 1250
Date Date Gain Gain
------ ------- --------- ------------
12/31/2008 1/15/2009 $0.000000 $0.000000
---------- --------- --------- ---------
3/31/2009 4/15/2009 $0.000000 $0.000000
--------- --------- --------- ---------
6/30/2009 7/15/2009 $0.000000 $0.000000
--------- --------- --------- ---------
9/30/2009 10/15/2009 $0.000000 $0.000000
--------- ---------- --------- ---------
Totals $0.000000 $0.000000
------ --------- ---------
The distributions payable on January 15, 2010 to shareholders of record on December 31, 2009, as previously announced on December 15, 2009, are considered 2010 distributions for federal income tax purposes.
The company did not incur any foreign taxes during 2009. Stockholders are encouraged to consult with their personal tax advisors as to their specific tax treatment of BioMed Realty Trust distributions.
About BioMed Realty Trust
BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on Providing Real Estate to the Life Science Industry®. The company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed owns or has interests in 69 properties, representing 114 buildings with approximately 10.5 million rentable square feet. The company's properties are located predominantly in the major U.S. life science markets of Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/New Jersey, which have well-established reputations as centers for scientific research. Additional information is available at www.biomedrealty.com.
SOURCE BioMed Realty Trust, Inc.
